Similarly, CDH1 and PIK3CA have been commonly identified in invasive lobular breast carcinoma [29], but whether these concurrent mutations are sensitive to PI3K/Akt/mTOR agents remains to be confirmed. Here, MTOR is linked to invasive lobular breast carcinoma.